Chronic Obstructive Pulmonary Disorder (COPD) News and Research

RSS
The World Health Organisation (WHO) has described Chronic Obstructive Pulmonary Disorder (COPD) as a global epidemic; an estimated 210 million people have COPD worldwide and more than 3 million people died of the condition in 2005, which is equal to 5% of all deaths globally that year. Total deaths from COPD are projected to increase by more than 30% in the next 10 years without interventions to cut risks, particularly exposure to tobacco smoke.

The most common symptoms of COPD are breathlessness (or a "need for air"), abnormal sputum (a mix of saliva and mucus in the airway), and a chronic cough. Daily activities, such as walking up a short flight of stairs or carrying a suitcase, can become very difficult as the condition gradually worsens. There are significant unmet needs in the treatment of COPD including limited therapeutic options to improve lung function and control exacerbations.
Researchers use mouse models to explain the developmental process behind COPD

Researchers use mouse models to explain the developmental process behind COPD

Passive smoking exposure among kids greatly increases COPD risk late in life

Passive smoking exposure among kids greatly increases COPD risk late in life

Tonsil removal as a child could mean chest infections risk as adults

Tonsil removal as a child could mean chest infections risk as adults

An inclusive approach to COPD research: an interview with Dr David Leather

An inclusive approach to COPD research: an interview with Dr David Leather

Study could lead to potential new therapeutic target with fewer side effects for hypertension

Study could lead to potential new therapeutic target with fewer side effects for hypertension

Smokers who have COPD may face increased risk of getting small cell lung cancer

Smokers who have COPD may face increased risk of getting small cell lung cancer

Despite increased life expectancy, British people suffer from more medical ailments

Despite increased life expectancy, British people suffer from more medical ailments

Oxygen wristbands: an interview with Dr Gillian Lowrey

Oxygen wristbands: an interview with Dr Gillian Lowrey

Andor's Komet software used to automatically score modified 3D 'Comet' assay results

Andor's Komet software used to automatically score modified 3D 'Comet' assay results

Epicure project: an interview with Frédéric Cren

Epicure project: an interview with Frédéric Cren

Chronic obstructive pulmonary disease flare-ups: an interview with Dr. MeiLan Han, University of Michigan and Scott Cerreta, Director of Education, COPD Foundation

Chronic obstructive pulmonary disease flare-ups: an interview with Dr. MeiLan Han, University of Michigan and Scott Cerreta, Director of Education, COPD Foundation

3D scaffolds bring hope for lung regeneration

3D scaffolds bring hope for lung regeneration

COPD treatments: an interview with Professor Price, University of Aberdeen

COPD treatments: an interview with Professor Price, University of Aberdeen

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

COPD investigational treatments: an interview with Dr. Tunde Otulana, Senior Vice President, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

European Commission and Japan approve once-daily dual bronchodilator Ultibro Breezhaler (QVA149) nearly simultaneously, for COPD patients

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Improved lung function in patients with moderate asthma severity observed with investigational Tiotropium

Patients with COPD show improvements in lung function with olodaterol

Patients with COPD show improvements in lung function with olodaterol

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

Once-daily COPD portfolio data from Novartis presented at European Respiratory Society (ERS) Annual Congress

"Leukotriene B4" play opposing roles in turning inflammation on and off for allergic asthma, COPD

"Leukotriene B4" play opposing roles in turning inflammation on and off for allergic asthma, COPD

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants

Saltwater-treatment for cystic fibrosis: an interview with Matthew Allen, Program Director at Cambridge Consultants